Viking Global Investors is a global investment firm managing more than twenty billion in capital across long-short equity and long-only strategies. The firm was established in 1999 and has offices in Greenwich, New York City, Hong Kong, and London.
280 Park Ave
New York, 10017
New York, United States
|2017-09-13||BridgeBio Pharma||Series C||$135M||Aisling Capital, American International Group, Cormorant Asset Management, Janus Capital Group, Kohlberg Kravis Roberts & Co., and Perceptive Advisors|
|2017-07-19||Vets First Choice||Series E||$223M||Clayton Dubilier & Rice, Hillhouse Capital Management, Rock Springs Capital, Sequoia Capital, and Wellington Management|
|2017-06-16||Yes To||Series B||$56M|
|2017-06-01||Deciphera Pharmaceuticals||Series C||$52M||New Leaf Venture Partners, Redmile Group, and Sphera Funds|